Filing Details

Accession Number:
0001213900-20-016201
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-29 19:23:30
Reporting Period:
2020-05-27
Accepted Time:
2020-06-29 19:23:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158780 Pluristem Therapeutics Inc PSTI Biological Products, (No Disgnostic Substances) (2836) 980351734
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1810117 Partnership Limited - Capital Wolf Clover 24 Bodenhimer Street
Tel Aviv L3 6200838
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-27 90,000 $8.14 2,601,311 No 4 P Direct
Common Stock Acquisiton 2020-05-28 75,898 $8.16 2,677,209 No 4 P Direct
Common Stock Acquisiton 2020-05-31 1,797 $7.95 2,679,006 No 4 P Direct
Common Stock Acquisiton 2020-06-01 22,796 $7.85 2,701,802 No 4 P Direct
Common Stock Acquisiton 2020-06-02 117,489 $7.57 2,819,291 No 4 P Direct
Common Stock Acquisiton 2020-06-04 7,610 $7.86 2,826,901 No 4 P Direct
Common Stock Acquisiton 2020-06-05 60,000 $7.82 2,886,901 No 4 P Direct
Common Stock Acquisiton 2020-06-08 178,717 $7.36 3,065,618 No 4 P Direct
Common Stock Acquisiton 2020-06-09 72,142 $7.15 3,137,760 No 4 P Direct
Common Stock Acquisiton 2020-06-10 25,000 $6.91 3,162,760 No 4 P Direct
Common Stock Acquisiton 2020-06-18 49,000 $7.36 3,211,760 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.02 to $8.25 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.90 and $8.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $7.922485038 and $7.973781704 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $7.81 and $7.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.25 to $7.92 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.70 to $7.9994 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.30 to $7.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  8. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.05 to $7.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  9. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $6.90 and $6.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  10. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.2882 to $7.4119 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.